Fate Therapeutics Inc (FATE)

May 05, 2026

Fate Therapeutics (FATE) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

May 05, 2026

May 05, 2026

FDA selects Fate Therapeutics’ FT819 for manufacturing pilot program By Investing.com - Investing.com South Africa

May 05, 2026

May 05, 2026

FDA selects Fate Therapeutics’ FT819 for manufacturing pilot program - Investing.com

May 05, 2026

May 05, 2026

Fate Therapeutics selected for U.S. FDA chemistry, manufacturing, and controls development and readiness pilot program to support manufacturing readiness of FT819 - marketscreener.com

May 05, 2026

May 05, 2026

FDA picks Fate's lupus cell therapy for manufacturing-readiness pilot - Stock Titan

May 05, 2026

May 05, 2026

Fate Therapeutics Selected For U.S. FDA Chemistry, Manufacturing, And Controls Development And Readiness Pilot Program To Support Manufacturing Readiness Of Ft819 - TradingView

May 05, 2026

May 05, 2026

Fate Therapeutics Selected for U.S. FDA Chemistry, - GlobeNewswire

May 05, 2026

May 04, 2026

Off-the-shelf CAR-T studies target lupus, diabetes and cancer - Stock Titan

May 04, 2026

May 04, 2026

Fate Therapeutics announces three presentations at the 2026 ASGCT annual meeting highlighting off-the-shelf CAR T-cell therapy pipeline for cancer and autoimmune diseases - marketscreener.com

May 04, 2026

May 04, 2026

Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases - Yahoo Finance UK

May 04, 2026

May 04, 2026

H.C. Wainwright raises Fate Therapeutics price target to $7 on SLE data - Investing.com Canada

May 04, 2026

May 04, 2026

H.C. Wainwright Maintains Fate Therapeutics(FATE.US) With Buy Rating, Raises Target Price to $7 - Moomoo

May 04, 2026

May 03, 2026

FATE Stock Rises As Fate Therapeutics Showcases FT839 CAR T Data​ - StocksToTrade

May 03, 2026

May 03, 2026

MSN Money - MSN

May 03, 2026

May 01, 2026

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 01, 2026

May 01, 2026

New Fate hire gets 30,200 shares in Nasdaq-compliant award - Stock Titan

May 01, 2026

May 01, 2026

FATE Stock Price, Quote & Chart | FATE THERAPEUTICS INC (NASDAQ:FATE) - ChartMill

May 01, 2026

Apr 30, 2026

CAR-T Cell Therapy Market Will Generate Booming Growth Opportunities to 2030 | Novartis, Johnson & Johnson Services, Mustang, Sorrento Therapeutics, Fate Therapeutics etc. - industrytoday.co.uk

Apr 30, 2026

Apr 30, 2026

Single-dose FT819 data in 10 lupus patients heads to rheumatology meeting - Stock Titan

Apr 30, 2026

Apr 30, 2026

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting - ChartMill

Apr 30, 2026

Apr 24, 2026

Fate Therapeutics (NASDAQ: FATE) sets 2026 proxy votes and 7M-share plan boost - Stock Titan

Apr 24, 2026

Apr 24, 2026

Fate Therapeutics | DEF 14A: Definitive information statements - Moomoo

Apr 24, 2026

Apr 23, 2026

iPSC-Derived NK Cells Pipeline Set to Transform Cancer Immunotherapy Landscape with 15+ Emerging Therapies and Strong Innovation Momentum from Century Therapeutics, Fate Therapeutics | DelveInsight - Barchart.com

Apr 23, 2026

Apr 23, 2026

Redmile (NASDAQ: FATE) corrects cash-settled swap reference price - Stock Titan

Apr 23, 2026

Apr 23, 2026

iPSC-Derived NK Cells Pipeline Set to Transform Cancer - openPR.com

Apr 23, 2026

Apr 22, 2026

Redmile (NASDAQ: FATE) shifts stake to SPV in internal reorg - Stock Titan

Apr 22, 2026

Apr 21, 2026

FATE Financials: Income Statement, Balance Sheet & Cash Flow | Fate Therapeutic - Stock Titan

Apr 21, 2026

Apr 20, 2026

Fate Therapeutics (FATE) Stock: Why Market Expansion (Breakdown Watch) 2026-04-20Social Buzz - UBND thành phố Hải Phòng

Apr 20, 2026

Apr 17, 2026

Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases - marketscreener.com

Apr 17, 2026

Apr 17, 2026

Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at t - Sahm

Apr 17, 2026

Apr 17, 2026

Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Apr 17, 2026

Apr 16, 2026

Fate Therapeutics Announces Data Presentation Of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate For The Broad Treatment Of Hematological Malignancies And Autoimmune Diseases Without The Need For Conditioning Chemotherapy - marketscreener.com

Apr 16, 2026

Apr 16, 2026

Fate Therapeutics Details Off-the-Shelf CAR T Progress in Lupus and Solid Tumors at Needham Conference - MarketBeat

Apr 16, 2026

Apr 14, 2026

NK Cell Therapy Market Is Booming Rapidly with Strong Demand - openPR.com

Apr 14, 2026

Apr 13, 2026

Aug Wrap: Is Fate Therapeutics Inc part of any ETFDay Trade & Daily Stock Trend Reports - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

FATE Q4 2025 Earnings: Fate Therapeutics Inc. tops EPS estimates, reports no revenueTrend Analysis - Cổng thông tin điện tử tỉnh Lào Cai

Apr 13, 2026

Apr 10, 2026

Fate Therapeutics Inc stock (US3025491025): Is its iPSC platform strong enough to unlock biotech ups - AD HOC NEWS

Apr 10, 2026

Apr 10, 2026

Fate Therapeutics Inc stock: Q2 2026 conferences signal active engagement - AD HOC NEWS

Apr 10, 2026

Apr 10, 2026

FATE Q4 2025 Earnings: Fate Therapeutics Inc. posts narrow EPS beat, no revenue reportedElite Trading Signals - UBND thành phố Hải Phòng

Apr 10, 2026

Apr 09, 2026

Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences - GlobeNewswire

Apr 09, 2026

Apr 09, 2026

Fate Therapeutics plans appearances at 5 investor conferences by June - Stock Titan

Apr 09, 2026

Apr 02, 2026

Fate Therapeutics reports new employee inducement award under Nasdaq listing rule 5635(c)(4) - marketscreener.com

Apr 02, 2026

Apr 02, 2026

Fate Therapeutics Announces New Employee Inducement Award - National Today

Apr 02, 2026

Apr 02, 2026

Fate Therapeutics Inc (F6T.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 02, 2026

Mar 31, 2026

Street Watch: Is Fate Therapeutics Inc subject to activist investor interest2026 Rallies & Weekly Breakout Watchlists - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

FATE Should I Buy - Intellectia AI

Mar 31, 2026

Mar 31, 2026

Fate Therapeutics Inc Stock: Pioneering iPSC Cell Therapies Amid Biotech Volatility - AD HOC NEWS

Mar 31, 2026

Mar 31, 2026

Fate Therapeutics (NASDAQ:FATE) Share Price Passes Below 200-Day Moving AverageHere's What Happened - MarketBeat

Mar 31, 2026

Mar 27, 2026

Scalable Biotech Manufacturing Unlocks a $14B Market - Benzinga

Mar 27, 2026

Mar 27, 2026

Scalable Biotech Manufacturing Unlocks a $14B Market - Sahm

Mar 27, 2026

Mar 26, 2026

Vanguard (FATE) reports 0 shares after internal realignment - Stock Titan

Mar 26, 2026

Mar 24, 2026

Mizuho reiterates Fate Therapeutics stock rating on trial progress By Investing.com - Investing.com Canada

Mar 24, 2026

Mar 23, 2026

Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Mar 23, 2026

Mar 21, 2026

Take Profit: Will Fate Therapeutics Inc outperform small cap indexes2026 Volatility Report & Long Hold Capital Preservation Tips - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Fate Therapeutics Inc stock faces analyst caution amid biotech pipeline scrutiny - AD HOC NEWS

Mar 21, 2026

Mar 18, 2026

The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed - marketscreener.com

Mar 18, 2026

Mar 17, 2026

Fate Therapeutics, Inc. (NASDAQ:FATE) Short Interest Down 14.1% in February - MarketBeat

Mar 17, 2026

Mar 17, 2026

Big Picture: Can Fate Therapeutics Inc beat the S P 5002026 Intraday Action & Trade Opportunity Analysis Reports - baoquankhu1.vn

Mar 17, 2026